UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis

Cancer discovery, 2020-02, Vol.10 (2), p.254-269

2020

Volltextzugriff (PDF)

BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association

Cell reports (Cambridge), 2018-11, Vol.25 (6), p.1501-1510.e3

2018

Volltextzugriff (PDF)

CADM1 is a TWIST1-regulated suppressor of invasion and survival

Cell death & disease, 2019-03, Vol.10 (4), p.281-281, Article 281

2019

Volltextzugriff (PDF)

Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma

Cell death discovery, 2024-04, Vol.10 (1), p.175-175, Article 175

2024

Volltextzugriff (PDF)

Lysine methylation promotes VEGFR-2 activation and angiogenesis

Science signaling, 2013-12, Vol.6 (304), p.ra104

2013

Volltextzugriff (PDF)

Cell Adhesion Molecules in Plasticity and Metastasis

Molecular cancer research, 2021-01, Vol.19 (1), p.25-37

2021

Volltextzugriff (PDF)

Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

Molecular cancer research, 2022-08, Vol.20 (8), p.1260-1271

2022

Volltextzugriff (PDF)

Multi‐omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors

Pigment cell and melanoma research, 2014-05, Vol.27 (3), p.479-484

2014

Volltextzugriff (PDF)

Of Mice and Melanoma: PDX System for Modeling Personalized Medicine

Clinical cancer research, 2016-04, Vol.22 (7), p.1550-1552

2016

Volltextzugriff (PDF)

Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (15), p.4122-4132

2014

Volltextzugriff (PDF)

The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner

Pigment cell and melanoma research, 2019-09, Vol.32 (5), p.687-696

2019

Volltextzugriff (PDF)

Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo

Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.84-95

2018

Volltextzugriff (PDF)

Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma

Molecular cancer research, 2014-05, Vol.12 (5), p.795-802

2014

Volltextzugriff (PDF)

αC IN, αC OUT—that's what it's all about

Pigment cell and melanoma research, 2017-03, Vol.30 (2), p.177-178

2017

Volltextzugriff (PDF)

In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (23), p.7101-7110

2013

Volltextzugriff (PDF)

A STATement on Vemurafenib-Resistant Melanoma

Journal of investigative dermatology, 2013-08, Vol.133 (8), p.1928-1929

2013

Volltextzugriff (PDF)

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth

Journal of visualized experiments, 2021-09 (175)

2021

Volltextzugriff (PDF)

Of Mice and Melanoma

Clinical cancer research, 2016-02, Vol.22 (7), p.1550-1552

2016

Volltextzugriff (PDF)

[alpha]C IN,[alpha]C OUT--that's what it's all about

Pigment cell and melanoma research, 2017-03, Vol.30 (2), p.177

2017

Volltextzugriff (PDF)

Abstract 1361: Astrocytes activate neuronal programming in melanoma brain metastases

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1361-1361

2023

Volltextzugriff (PDF)

Abstract A31: 14-3-3 binding sites in full-length and splice variant forms of BRAF V600E modulate the response to RAF inhibitors

Clinical cancer research, 2017-01, Vol.23 (1_Supplement), p.A31-A31

2017

Volltextzugriff (PDF)

Abstract 105: CADM1 is a TWIST1-regulated suppressor of melanoma invasion and survival

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.105-105

2018

Volltextzugriff (PDF)

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth

Journal of visualized experiments, 2021-09 (175)

2021

Volltextzugriff (PDF)

Abstract 4089: CADM1 is a TWIST1 regulated suppressor of melanoma invasion

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4089-4089

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)
Dissertationen
(1)

Sprache

Englisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(15)
Oncology
(11)
Cell Biology
(10)
Humans
(10)
Animals
(9)
Mice
(8)
Melanoma
(7)
Cell Line, Tumor
(6)
Female
(6)
Indoles - Pharmacology
(5)
Melanoma - Drug Therapy
(5)
Melanoma - Pathology
(5)
Mice, Nude
(5)
Protein Kinase Inhibitors - Pharmacology
(5)
Proto-Oncogene Proteins B-Raf - Genetics
(5)
Sulfonamides - Pharmacology
(5)
Apoptosis
(4)
Dermatology
(4)
Proto-Oncogene Proteins B-Raf - Antagonists & Inhibitors
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis

BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association

CADM1 is a TWIST1-regulated suppressor of invasion and survival

Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma

Lysine methylation promotes VEGFR-2 activation and angiogenesis

Cell Adhesion Molecules in Plasticity and Metastasis

Multi-omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

Multi‐omics profiling shows BAP1 loss is associated with upregulated cell adhesion molecules in uveal melanoma

Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors

Of Mice and Melanoma: PDX System for Modeling Personalized Medicine

Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor

The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner

Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo

Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma

αC IN, αC OUT—that's what it's all about

In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors

A STATement on Vemurafenib-Resistant Melanoma

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth

Of Mice and Melanoma

[alpha]C IN,[alpha]C OUT--that's what it's all about

Abstract 1361: Astrocytes activate neuronal programming in melanoma brain metastases

Abstract A31: 14-3-3 binding sites in full-length and splice variant forms of BRAF V600E modulate the response to RAF inhibitors

Abstract 105: CADM1 is a TWIST1-regulated suppressor of melanoma invasion and survival

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth

Abstract 4089: CADM1 is a TWIST1 regulated suppressor of melanoma invasion

Suchergebnisse filtern